An unusual case of primary retroperitoneal germ cell tumor is presented. Criteria for considering such a diagnosis in patients with apparent poorly differentiated carcinomas are discussed. An interesting hypothesis is presented to explain the hormonal abnormalities observed.
Get full access to this article
View all access options for this article.
References
1.
AndersonT., WaldmannT.A., JavadpourN., GlatsteinE.: Testicular germ cell neoplasms: recent advances in diagnosis and therapy.Ann. Intern. Med., 90: 373–385, 1979.
2.
BurtM.E., JavadpourN.: Germ-cell tumors in patients with apparently normal testes.Cancer, 47: 1911–1915, 1981.
3.
D'AoustJ.C., PrestaykoA.W., EinhornL.H.: Cisplatin, bleomycin and vindesine combination chemotherapy of testicular tumors: an analysis.Med. Pediatr. Oncol., 6: 195–205, 1979.
4.
EinhornL.H., DonohueJ.D.: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.Ann. Intern. Med., 87: 293–298, 1977.
5.
EinhornL.H., WilliamsS.D.: Chemotherapy of disseminated testicular cancer: A random prospective study.Cancer, 46: 1339–1344, 1980.
6.
FoxR.M., WoodsR.L., TettersalM.H.N.: Undifferentiated carcinoma in young men: the atypical teratoma syndrome.Lancet, 1: 1316–1319, 1979.
MaatmanT., BukowskiR.M., MontieJ.E.: Retroperitoneal malignancies several years after initial treatment of germ cell cancer of the testis.Cancer, 54: 1962–1965, 1984.
MearesE.M.J.R., BriggsE.N.: Occult seminoma of the testis masquerading as primary extragonadal germinal neoplasms.Cancer, 30: 300–306, 1972.
14.
RichardsonR.L., SchoumacherR.A., FerM.F., HandeK.R., ForbesJ.T., OldhamR.K., GrecoF.A.: The unrecognized extragonadal germ cell cancer syndrome.Ann. Intern. Med., 94: 181–186, 1981.
15.
SilvermanN.A., SabistonD.C.: Primary tumors of the mediastinum.Curr. Probl. Cancer, 2: 1–54, 1977.
16.
UlbrightT.M., LoehrerP.J., RothL.M., EinhornL.H., WilliamsS.D., ClarkS.A.: The development of non germ cell malignancies within germ cell tumors.Cancer, 54: 1824–1833, 1984.